Tranexamic acid
Top View
- Congenital Platelet Disorders Mike Makris Sheffield, UK Disclosures for Mike Makris
- ANTICOAGULATION RELATED BLEEDING - GUIDELINE SUMMARY Click Here for the Full Thrombosis Prevention Investigation and Management of Anticoagulation Guideline
- Emergency Reversal of Anticoagulant Therapy (Bleeding & Emergency Surgery)
- UNC Healthcare Guidelines for Tranexamic Acid in Major Trauma
- Tranexamic Acid in a Case Report of Life-Threatening Nontraumatic Hemorrhage in Immune Thrombocytopenic Purpura
- Essential List of Medicinal Products for Rare Diseases: Recommendations from the Irdirc Rare Disease Treatment Access Working Group William A
- Novel Treatments in Haemophilia and Other Bleeding Disorders: a Periodic EHC Review
- Recombinant Factor Viia and Tranexamic Acid in Subgaleal Hemorrhage Sumesh Thomas1*, Arun Sundaram2, Nadira Rashid2 and Macgregor Steel3
- List of Fdcs (Under Category 'C') Permitted for Continued Manufacturing and Marketing Under 18 Month Policy Decision
- Transfusion Replacement Strategies in Jehovah's Witnesses and Others Who Decline Blood Products
- 5 TIWIKLY 5 Things I Wish I Knew Last Year (2015)
- Long-Term Care Drug Database System: Drugs by NDC Class Code, Drug Code and Name
- Guideline for Management of Over-Anticoagulation
- Tranexamic Acid Information for Parents and Carers What Is Tranexamic Acid? Tranexamic Acid Is One of a Group of Medicines Called Antifibrinolytics
- Prothrombin Complex Concentrates in Post-Traumatic Hemorrhage: a Review
- Coagulation Factor Products
- Vitamin K Antagonist – Interferes with Cyclic Interconversion of Vitamin K
- Management of Critically Ill Patients with Liver Disease: a Conversation in Coagulation a Presentation for Healthtrust Members May 14, 2021